Related references
Note: Only part of the references are listed.Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies
Thomas Vogels et al.
BIOLOGICAL PSYCHIATRY (2020)
Amyloid-Beta (Aβ) Plaques Promote Seeding and Spreading of Alpha-Synuclein and Tau in a Mouse Model of Lewy Body Disorders with Aβ Pathology
Fares Bassil et al.
NEURON (2020)
Regulation of α-synuclein by chaperones in mammalian cells
Bjorn M. Burmann et al.
NATURE (2020)
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys
Mihalis S. Kariolis et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Cell-to-Cell Transmission of Tau and alpha-Synuclein
Norihito Uemura et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Dual Targeting of Monomeric Tau and α-Synuclein Aggregation: A New Multitarget Therapeutic Strategy for Neurodegeneration
Moustafa T. Gabr et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults
Shama Karanth et al.
JAMA NEUROLOGY (2020)
The Role of P2X7 Receptor in Alzheimer's Disease
Linda Francistiova et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Viral Delivery of Non-Mutated Human Truncated Tau to Neurons Recapitulates Key Features of Human Tauopathy in Wild-Type Mice
Thomas Vogels et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy
Yuta Takaichi et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution
Tanis J. Ferman et al.
NEUROLOGY (2020)
Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
Antonio Dominguez-Meijide et al.
SCIENTIFIC REPORTS (2020)
Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease
Malcolm Roberts et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Building blocks for bispecific and trispecific antibodies
Xiufeng Wu et al.
METHODS (2019)
Tau antibody chimerization alters its charge and binding, thereby reducing its cellular uptake and efficacy
Erin E. Congdon et al.
EBIOMEDICINE (2019)
α-synuclein in the pathophysiology of Alzheimer's disease
Daniel Twohig et al.
MOLECULAR NEURODEGENERATION (2019)
Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tau
Matthias Brendel et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
The Role of Antibodies and Their Receptors in Protection Against Ordered Protein Assembly in Neurodegeneration
Taxiarchis Katsinelos et al.
FRONTIERS IN IMMUNOLOGY (2019)
Intersection of pathological tau and microglia at the synapse
Thomas Vogels et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like model
Markus Mandler et al.
ALZHEIMERS & DEMENTIA (2019)
Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy
Tiffany Wu et al.
CELL REPORTS (2019)
Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
Naomi P. Visanji et al.
TRANSLATIONAL NEURODEGENERATION (2019)
Interaction between Copper Chaperone Atox1 and Parkinson's Disease Protein α-Synuclein Includes Metal-Binding Sites and Occurs in Living Cells
Istvan Horvath et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor
Kevin Carvalho et al.
BRAIN (2019)
Structure-based inhibitors of amyloid beta core suggest a common interface with tau
Sarah L. Griner et al.
ELIFE (2019)
Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders
David Coughlin et al.
ANNALS OF NEUROLOGY (2019)
Increasing the buffering capacity of minimal media leads to higher protein yield
Stephan B. Azatian et al.
JOURNAL OF BIOMOLECULAR NMR (2019)
Emerging Roles of Complement Protein C1q in Neurodegeneration
Kyoungjoo Cho
AGING AND DISEASE (2019)
Influence of Lewy Pathology on Alzheimer's Disease Phenotype: A Retrospective Clinico-Pathological Study
Jennifer Roudil et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo
Marc Vandermeeren et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Complement analysis in the era of targeted therapeutics
Zoltan Prohaszka et al.
MOLECULAR IMMUNOLOGY (2018)
Gray matter atrophy in dementia with Lewy bodies with and without concomitant Alzheimer's disease pathology
Jessica J. van der Zande et al.
NEUROBIOLOGY OF AGING (2018)
Improving the identification of dementia with Lewy bodies in the context of an Alzheimer's-type dementia
Alan J. Thomas et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model
Krystal Herline et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model
Fernando Goni et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
A common antigenic motif recognized by naturally occurring human VH5-51/VL4-1 anti-tau antibodies with distinct functionalities
Adrian Apetri et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau
Jeroen van Ameijde et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau
Jean-Philippe Courade et al.
ACTA NEUROPATHOLOGICA (2018)
New classification of tauopathies
G. U. Hoeglinger et al.
REVUE NEUROLOGIQUE (2018)
Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies
Borislav Dejanovic et al.
NEURON (2018)
Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer's Disease
Alexandra Litvinchuk et al.
NEURON (2018)
In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
Rosa Crespo et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis
David Irwin et al.
LANCET NEUROLOGY (2017)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
Greta Hultqvist et al.
THERANOSTICS (2017)
Characterization of TauC3 antibody and demonstration of its potential to block tau propagation
Samantha B. Nicholls et al.
PLOS ONE (2017)
Production of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases
Fernando Goni et al.
SCIENTIFIC REPORTS (2017)
Interactions of pathological proteins in neurodegenerative diseases
Tara L. Spires-Jones et al.
ACTA NEUROPATHOLOGICA (2017)
Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro
Chloe K. Nobuhara et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Immunological memory to hyperphosphorylated tau in asymptomatic individuals
Gabriel Pascual et al.
ACTA NEUROPATHOLOGICA (2017)
Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies
Toshiki Uchihara et al.
ACTA NEUROPATHOLOGICA (2016)
Immunotherapeutic Approaches Targeting Amyloid-beta, alpha-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders
Elvira Valera et al.
NEUROTHERAPEUTICS (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Soyon Hong et al.
SCIENCE (2016)
Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement
Seung-Hye Lee et al.
CELL REPORTS (2016)
Alzheimer's disease AdvaxCpG-adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules
Hayk Davtyan et al.
SCIENTIFIC REPORTS (2016)
Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
Jens Wagner et al.
ACTA NEUROPATHOLOGICA (2015)
Alzheimer's disease vaccine development: A new strategy focusing on immune modulation
Dante J. Marciani
JOURNAL OF NEUROIMMUNOLOGY (2015)
Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy
Asami Kondo et al.
NATURE (2015)
Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain
Shuko Takeda et al.
NATURE COMMUNICATIONS (2015)
The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset
Johannes Levin et al.
ACTA NEUROPATHOLOGICA (2014)
Alpha-synuclein and tau: teammates in neurodegeneration?
Simon Moussaud et al.
MOLECULAR NEURODEGENERATION (2014)
Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer's disease
Eva Kontsekova et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease
Jens Wagner et al.
ACTA NEUROPATHOLOGICA (2013)
Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
Jing L. Guo et al.
CELL (2013)
Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance
Erin E. Congdon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
Kiran Yanamandra et al.
NEURON (2013)
N-terminal acetylation of α-synuclein induces increased transient helical propensity and decreased aggregation rates in the intrinsically disordered monomer
Lijuan Kang et al.
PROTEIN SCIENCE (2012)
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Yaroslau Compta et al.
BRAIN (2011)
Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains
Jian-Quan Shi et al.
BRAIN RESEARCH (2011)
Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer's Disease Model
Masashi Kitazawa et al.
JOURNAL OF IMMUNOLOGY (2011)
Complement in the brain
Robert Veerhuis et al.
MOLECULAR IMMUNOLOGY (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
Crucial Role of Aspartic Acid at Position 265 in the CH2 Domain for Murine IgG2a and IgG2b Fc-Associated Effector Functions
Lucie Baudino et al.
JOURNAL OF IMMUNOLOGY (2008)
The β-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy
Katrin Eckermann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Small ubiquitin-related modifier (SUMO)-specific proteases -: Profiling the specificities and activities of human SENPs
Jowita Mikolajczyk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Initiation and synergistic fibrillization of tau and alpha-synuclein
BI Giasson et al.
SCIENCE (2003)
Imaging Aβ plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative
WE Klunk et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease
KA Jellinger et al.
JOURNAL OF NEURAL TRANSMISSION (2002)
Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local β-structure
M von Bergen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure
M von Bergen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
